A detailed history of Signaturefd, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Signaturefd, LLC holds 60 shares of MYGN stock, worth $769. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60
Previous 60 -0.0%
Holding current value
$769
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$13.91 - $21.32 $834 - $1,279
60 New
60 $1,000
Q1 2023

Apr 28, 2023

BUY
$15.26 - $23.75 $167 - $261
11 New
11 $0
Q2 2022

Aug 10, 2022

BUY
$16.45 - $25.88 $180 - $284
11 Added 11.83%
104 $2,000
Q4 2021

Jan 25, 2022

BUY
$24.13 - $32.63 $2,244 - $3,034
93 New
93 $3,000
Q4 2019

Feb 05, 2020

SELL
$20.93 - $35.1 $12,599 - $21,130
-602 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$22.08 - $47.08 $13,292 - $28,342
602 New
602 $17,000
Q3 2018

Nov 15, 2018

SELL
$37.57 - $50.34 $10,707 - $14,346
-285 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$27.75 - $40.17 $7,908 - $11,448
285 New
285 $11,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.03B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.